Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.08% |
| 2 | Financials | 6.03% |
| 3 | Industrials | 5.01% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Healthcare | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
AT&T
T
$168B
| $124M | 0.08% |
+4,210,505
| New | +$115M |
|
252
Northrop Grumman
NOC
$81.8B
| $123M | 0.08% |
401,734
-14,606
| -4% | -$4.39M |
|
253
MSC Industrial Direct
MSM
$6.7B
| $123M | 0.08% |
1,275,343
+1,032,259
| +425% | +$86.3M |
|
254
CALL
Gilead Sciences
GILD
$168B
| $123M | 0.07% |
1,716,800
-199,300
| -10% | -$15.1M |
|
255
PayPal
PYPL
$50.5B
| $123M | 0.07% |
1,664,208
+1,518,323
| +1,041% | +$110M |
|
256
Dell
DELL
$285B
| $122M | 0.07% |
5,352,115
+119,115
| +2% | +$2.7M |
|
257
Trinity Industries
TRN
$2.29B
| $122M | 0.07% |
4,524,183
+1,300,381
| +40% | +$32.4M |
|
258
Restaurant Brands International
QSR
$25.6B
| $122M | 0.07% |
1,981,556
-404,588
| -17% | -$25.9M |
|
259
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
| $122M | 0.07% |
960,100
+128,700
| +15% | +$16.2M |
|
260
Lear
LEA
$8.12B
| $122M | 0.07% |
687,947
+15,017
| +2% | +$2.64M |
|
261
Edwards Lifesciences
EW
$54B
| $121M | 0.07% |
3,227,325
-787,512
| -20% | -$28.9M |
|
262
Devon Energy
DVN
$49.9B
| $121M | 0.07% |
2,923,669
-2,885,820
| -50% | -$109M |
|
263
CALL
Wells Fargo
WFC
$264B
| $121M | 0.07% |
1,989,000
-160,900
| -7% | -$9.09M |
|
264
PUT
Biogen
BIIB
$30.1B
| $120M | 0.07% |
377,200
+88,200
| +31% | +$28.3M |
|
265
PUT
Lam Research
LRCX
$390B
| $120M | 0.07% |
6,521,000
+4,108,000
| +170% | +$80.7M |
|
266
Huntsman Corp
HUN
$1.83B
| $120M | 0.07% |
3,604,506
+2,471,109
| +218% | +$75.7M |
|
267
PUT
NetEase
NTES
$81.9B
| $120M | 0.07% |
1,736,500
-2,500
| -0.1% | -$156K |
|
|
AVXS
268
DELISTED
AveXis, Inc. Common Stock
AVXS
| $119M | 0.07% |
1,075,964
+79,743
| +8% | +$8M |
|
269
PUT
Intel
INTC
$493B
| $118M | 0.07% |
2,566,200
+618,100
| +32% | +$27M |
|
270
PUT
JD.com
JD
$43.1B
| $118M | 0.07% |
2,852,100
+769,600
| +37% | +$30.3M |
|
271
PUT
SLB Ltd
SLB
$79.7B
| $117M | 0.07% |
1,743,400
+1,007,200
| +137% | +$65.3M |
|
272
DuPont de Nemours
DD
$19.5B
| $116M | 0.07% |
645,881
-526,520
| -45% | -$94.8M |
|
273
PUT
FedEx
FDX
$76.3B
| $116M | 0.07% |
466,200
+139,700
| +43% | +$31.9M |
|
274
PUT
Amgen
AMGN
$224B
| $116M | 0.07% |
666,200
+265,300
| +66% | +$47M |
|
275
The Mosaic Company
MOS
$7.34B
| $115M | 0.07% |
4,491,438
+1,898,682
| +73% | +$43.6M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.